FENNEC PHARMACEUTICALS INC. (FENC) Operating income 2016–2025
FENNEC PHARMACEUTICALS INC. (FENC) annual operating income history from SEC filings — each fiscal year as reported.
-$6.3MFY2025 · since FY2016: -$2.9M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | -344.6% |
| FY2024 | $2.6M | +120.1% |
| FY2023 | -$12.8M | +43.5% |
| FY2022 | -$22.6M | -31.2% |
| FY2021 | -$17.2M | +3.7% |
| FY2020 | -$17.9M | -37.5% |
| FY2019 | -$13.0M | -25.0% |
| FY2018 | -$10.4M | -49.7% |
| FY2017 | -$7.0M | -142.1% |
| FY2016 | -$2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FENC financial trends
FENC RevenueFENC Net incomeFENC Net marginFENC Gross profitFENC Gross marginFENC Operating marginFENC Operating cash flowFENC Free cash flowFENC Capital expendituresFENC Return on equityFENC Stock buybacksFENC Dividends paidFENC Total assetsFENC Total liabilitiesFENC Shareholders’ equityFENC overview →